However, this comparison, the present result of mostly mild to moderate severity and the absence of an increasing trend in the incidence over time support a low risk for clinically significant gastrointestinal symptoms.
← all excerpts
Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial.
1
—
—